Syon Capital LLC Invests $13.23 Million in SPDR S&P China ETF (NYSEARCA:GXC)

Syon Capital LLC bought a new position in shares of SPDR S&P China ETF (NYSEARCA:GXC) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 194,171 shares of the company’s stock, valued at approximately $13,227,000. SPDR S&P China ETF accounts for approximately 0.9% of Syon Capital LLC’s portfolio, making the stock its 21st biggest holding. Syon Capital LLC owned approximately 1.33% of SPDR S&P China ETF as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in GXC. 3EDGE Asset Management LP bought a new stake in SPDR S&P China ETF in the 4th quarter valued at $47,836,000. Cerity Partners LLC acquired a new position in SPDR S&P China ETF in the 4th quarter valued at $4,084,000. Parcion Private Wealth LLC raised its holdings in SPDR S&P China ETF by 16.5% in the 4th quarter. Parcion Private Wealth LLC now owns 281,607 shares of the company’s stock valued at $19,183,000 after acquiring an additional 39,845 shares in the last quarter. Prism Advisors Inc. acquired a new position in SPDR S&P China ETF in the 4th quarter valued at $2,019,000. Finally, EisnerAmper Wealth Management Corporate Benefits LLC acquired a new position in SPDR S&P China ETF in the 4th quarter valued at $1,061,000.

SPDR S&P China ETF Trading Up 1.9 %

NYSEARCA GXC traded up $1.28 during midday trading on Friday, hitting $69.44. The company had a trading volume of 22,272 shares, compared to its average volume of 156,118. The company has a market capitalization of $506.91 million, a PE ratio of 8.99 and a beta of 0.86. The firm has a 50-day moving average price of $65.89 and a 200-day moving average price of $66.79. SPDR S&P China ETF has a twelve month low of $59.45 and a twelve month high of $81.72.

About SPDR S&P China ETF

SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors.